Literature DB >> 18761657

Lack of somatic alterations of MC1R in primary melanoma.

R D Kim1, J A Curtin, Boris C Bastian.   

Abstract

Germline variation of the melanocortin 1 receptor gene (MC1R) is a risk factor for cutaneous melanoma. Recent studies have indicated that the risk is significantly higher for melanomas with somatic BRAF mutations, suggesting that MC1R variants may have a more specific role than their demonstrated effects on skin and hair pigmentation. To address the possibility that MC1R may act like a tumor suppressor gene by creating a permissive condition for melanocytes with specific somatic mutations to proliferate or survive, we analyzed 103 primary melanomas for somatic MC1R mutations and copy number alterations. This cohort included melanomas from skin with and without chronic sun-induced damage, mucosal membranes, and acral skin (palms, soles, and subungual). We did not find somatic mutations or frequent DNA copy number alterations at the MC1R locus, nor any skewed pattern of copy number alterations that would favor one allele type over the other. In conclusion, our findings indicate that MC1R is not a frequent target of somatic alterations in melanoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18761657      PMCID: PMC2825252          DOI: 10.1111/j.1755-148X.2008.00497.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  18 in total

1.  Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?

Authors:  J S Palmer; D L Duffy; N F Box; J F Aitken; L E O'Gorman; A C Green; N K Hayward; N G Martin; R A Sturm
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma.

Authors:  P Valverde; E Healy; S Sikkink; F Haldane; A J Thody; A Carothers; I J Jackson; J L Rees
Journal:  Hum Mol Genet       Date:  1996-10       Impact factor: 6.150

3.  Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B.

Authors:  A K Chakraborty; Y Funasaka; A Slominski; G Ermak; J Hwang; J M Pawelek; M Ichihashi
Journal:  Biochim Biophys Acta       Date:  1996-08-28

4.  Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes.

Authors:  E Schauer; F Trautinger; A Köck; A Schwarz; R Bhardwaj; M Simon; J C Ansel; T Schwarz; T A Luger
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

5.  Quantitative measures of the effect of the melanocortin 1 receptor on human pigmentary status.

Authors:  Lisa Naysmith; Karen Waterston; Tom Ha; Niamh Flanagan; Yvonne Bisset; Amanda Ray; Kazumasa Wakamatsu; Shosuke Ito; Jonathan L Rees
Journal:  J Invest Dermatol       Date:  2004-02       Impact factor: 8.551

6.  Determinants of BRAF mutations in primary melanomas.

Authors:  Janet L Maldonado; Jane Fridlyand; Hetal Patel; Ajay N Jain; Klaus Busam; Toshiro Kageshita; Tomomichi Ono; Donna G Albertson; Dan Pinkel; Boris C Bastian
Journal:  J Natl Cancer Inst       Date:  2003-12-17       Impact factor: 13.506

Review 7.  The genetics of sun sensitivity in humans.

Authors:  Jonathan L Rees
Journal:  Am J Hum Genet       Date:  2004-09-15       Impact factor: 11.025

8.  Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles.

Authors:  Kimberley A Beaumont; Sri N Shekar; Sri L Shekar; Richard A Newton; Michael R James; Jennifer L Stow; David L Duffy; Richard A Sturm
Journal:  Hum Mol Genet       Date:  2007-07-05       Impact factor: 6.150

9.  Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA.

Authors:  V Chhajlani; J E Wikberg
Journal:  FEBS Lett       Date:  1992-09-14       Impact factor: 4.124

10.  Human melanocortin 1 receptor (MC1R) gene variants alter melanoma cell growth and adhesion to extracellular matrix.

Authors:  Samantha J Robinson; Eugene Healy
Journal:  Oncogene       Date:  2002-11-14       Impact factor: 9.867

View more
  1 in total

1.  Examination of Smad2 and Smad4 copy-number variations in skin cancers.

Authors:  Yong Shao; Jie Zhang; Richu Zhang; Jun Wan; Wei Zhang; Bo Yu
Journal:  Clin Transl Oncol       Date:  2012-02       Impact factor: 3.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.